November 15, 2022 • 17:00 - 18:00

Top 10 and beyond: what’s next for Canadian life sciences

A part of the “Life sciences in Canada: new frontiers, new strategies” series


Join us in this series on topics and trends taking place in Canada’s rapidly transforming life sciences ecosystem. Industry players, investors, and advisors on both sides of the Canada-U.S. border will want to join our interdisciplinary team for discussions on where the sector in Canada is headed—from product liability claim strategy and drug pricing to procurement, biometrics and more.

Top 10 and beyond: what’s next for Canadian life sciences

With a range of changes underway for Canadian pharmaceutical, medical device, biotech and other life sciences companies, we explore the top 10 developments in these spaces and their impact on business.

This session will be presented in English.

Time: 12:00 – 1:00 p.m. EST Presentation
11:45 a.m. EST Webinar opens

Ontario: This program is eligible for 60 Substantive minutes.
New York: This program contains 1.0 Areas of Professional Practice credit. This course content is appropriate for transitional and non-transitional attorneys.

Be sure to register for the remaining sessions in this series at